CAPA Workflow Automation in MedTech – ISO 13485 and Power Platform

CAPA (Corrective and Preventive Action) is a systematic process for identifying, documenting, correcting and preventing nonconformities in the quality management system. In medtech it is one of the core processes required by ISO 13485 (section 8.5) and FDA 21 CFR Part 820.100. Without a functioning CAPA – no certification, no market.

In practice CAPA still lives in three tools in many companies: Excel (register), Word (forms), mailbox (communication). The result is no audit trail in a single system, risk of lost records, inconsistent form versions between departments and weeks to close a single CAPA. In FDA or TÜV audits it is the area generating the most observations and nonconformities.

CAPA workflow automation has two dimensions: operational (shrinking CAPA cycle from months to weeks) and regulatory (compliance with audit trail and e-signature requirements). Without both dimensions the investment is not justified – operational only is unacceptable to the auditor, regulatory only causes user rejection.

The first stage is identification and registration of the CAPA source. Sources are typically: customer complaints, internal audit nonconformities, production failures, post-market surveillance reports, risks identified by risk management. Each source must have a unique identifier, date, description and initial classification (severity).

The second stage is investigation – root cause analysis. Tools used here include 5 Why, fishbone diagram, FMEA. The output is a documented root cause description with justification. The investigator must be named, and the investigation completion date defined.

The third stage is the action plan – a plan of corrective and preventive actions. Each action has an owner, a deadline, resources and a success criterion. The plan must be approved by the Quality Manager or equivalent.

The fourth stage is implementation – executing the plan. Each action is marked complete with evidence (document, screenshot, signature). All of this lives in the audit trail.

The fifth stage is the effectiveness check – verifying after a defined period (typically 3–6 months) that the CAPA actions actually removed the cause. This is often the weakest stage in classic CAPA, because without a workflow nobody returns to it after 3 months. After a positive check, the CAPA is formally closed.

ISO 13485 is the baseline standard for medtech. It requires a documented CAPA process, traceability of every decision, record retention of at least 5 years (often more, depending on product), and periodic CAPA effectiveness reviews by management.

FDA 21 CFR Part 11 (electronic records, electronic signatures) is required for sales to the US market and is the most rigorous standard. It requires: Computer System Validation (CSV), audit trail with a timestamp for every change, e-signature with two-factor verification (typically login + password + one-time code), unbreakable linking of the signature to the document, retention of electronic records for the mandated period.

MDR (Medical Device Regulation) in Europe adds post-market surveillance and Periodic Safety Update Reports (PSUR) fed by CAPA data. The workflow must therefore support CAPA aggregation per product into PSUR reports.

Other sector regulations (IVDR, IEC 62304 for software as a medical device, GxP for pharmaceuticals) add their own requirements. They all share a common denominator: audit trail + e-signature + traceability + retention. These are the elements the workflow must guarantee by design – not as an add-on.

A standard CAPA workflow architecture in the Microsoft ecosystem has four layers: document (SharePoint), process data (Dataverse), workflow (Power Automate) and interface (Power Apps + Teams).

SharePoint stores CAPA documents (investigation report, action plan, implementation evidence), with retention policy, sensitivity labels, audit trail and versioning. For FDA Part 11 compliance, additional configuration is required: read-only after signing, immutable storage, retention policy of 5+ years.

Dataverse holds CAPA process data – each CAPA as a record with fields: ID, status, source type, severity, owner, dates, related products, root cause. Dataverse provides native audit trail of every change, RBAC and scalable performance.

Power Automate orchestrates the workflow – triggers notifications, automatic escalations on SLA breach, effectiveness check reminders, PSUR report generation, integrations with external systems (PLM, ERP, post-market surveillance tools).

Power Apps + Teams form the user interface – Power App for advanced screens (investigation forms, action plan management, Quality Manager dashboards), Teams for notifications and lightweight actions (confirm action item completion, e-signature). The whole stack rests on SharePoint governance – without governance it falls apart.

The hardest piece of FDA Part 11 compliance is e-signature. It requires two-factor identity verification (typically login + password + a second factor – one-time code or MFA), a permanent link between signature and document, an unchanging signature representation (Printed Name + Date + Reason) and protection against signature repudiation (non-repudiation).

In the Microsoft stack, FDA Part 11 e-signature usually requires: Entra ID with MFA for all CAPA users, integration with SharePoint sensitivity labels for immutable storage of signed documents, a dedicated Power Apps screen for e-signature (with reason, timestamp, IP) or integration with a third-party tool (DocuSign, Adobe Sign, ValidSign) – each offers a validated FDA Part 11 module.

The audit trail is the second pillar. Every change – a form field, a comment, a status change, an attachment – must be recorded with user, timestamp, before/after values, reason for change. Dataverse audit trail is natively sufficient with proper configuration. SharePoint adds document audit. Together they form an immutable log that an auditor can replay.

The third element is retention. ISO 13485 requires 5+ years, but many companies apply 10–15 years (or product life + 2 years). Microsoft Purview retention policies automate this at the organisation level.

Computer System Validation (CSV) is a mandatory stage for CAPA systems used in regulated industries. The requirement comes from FDA 21 CFR Part 11 and GAMP 5 (Good Automated Manufacturing Practice). In practice CSV has three phases: IQ (Installation Qualification – verifying the system is installed correctly), OQ (Operational Qualification – verifying it operates per specification) and PQ (Performance Qualification – verifying it meets user requirements in the production environment).

For Microsoft Power Platform solutions, CSV requires: documentation of User Requirements (URS), Functional Specification (FS), Design Specification (DS), a test plan, IQ/OQ/PQ reports and a traceability matrix between URS and tests. The full documentation set often runs 200–500 pages and is held as part of the QMS.

Critical decision: do we validate the entire Power Platform or just the specific CAPA workflow? Standard practice is to validate the specific application and treat Power Platform as infrastructure (with vendor qualification from Microsoft). Microsoft provides GxP attestation documentation, which makes this easier.

CSV typically takes 3–6 months and requires a quality specialist (not just the IT team). After the first rollout, subsequent CAPA applications are validated faster (2–4 weeks) using a first-time framework.

CAPA does not live in isolation – it is part of a wider QMS (Quality Management System). Typical integrations include: complaint management (source of CAPA), change control (changes triggered by CAPA), document control (procedures and instructions), training records (training tied to action items), risk management (CAPA from risk assessment), supplier management (CAPA from supplier complaints).

In the Microsoft ecosystem, typical integrations are: SharePoint Document Library as document control linked to CAPA records in Dataverse. Power BI for QMS dashboards – CAPA trends, closure time, source breakdown, effectiveness rate. Integration with a dedicated QMS (MasterControl, ETQ, Veeva, Greenlight Guru, Sparta TrackWise) via REST API – many organisations use a hybrid: Power Platform for modern UX + dedicated QMS for regulatory backbone.

The second area is integration with post-market surveillance. CAPA with source 'customer complaint' or 'adverse event' must aggregate to PSUR reports (MDR) or MDR reports (FDA 21 CFR 803). Power Automate and Power BI together deliver that aggregation from Dataverse.

The third area is AI – a newer layer worth designing with AI governance in mind. Microsoft Copilot can support the quality team in drafting investigation reports (with access to similar past CAPAs), analysing quarterly root cause patterns, generating draft PSUR reports. It requires AI governance tailored to medtech – not every AI model is appropriate for medical device data.

The first mistake is deploying technology without validation. A Power App built by a citizen developer used for CAPA records – but without IQ/OQ/PQ. In an audit it is non-compliant, even if it technically works. Validation is expensive (3–6 months) but mandatory.

The second mistake is no CAPA process design before automation. The Power Platform workflow replicates existing Excel chaos – the same workflow, the same gaps, only faster. First redesign the process with Quality, R&D and Operations; then implement the workflow.

The third mistake is inadequate e-signature. A 'click button with reason' implementation does not meet FDA Part 11 – no second factor, no non-repudiation. Either use a dedicated solution (DocuSign for Life Sciences, ValidSign) or build it on Entra ID MFA with proper documentation.

The fourth mistake is no effectiveness check in the workflow. This is the most often skipped stage – 3–6 months after CAPA closure the workflow should automatically ask the owner to verify effectiveness. Without it, CAPA is formally closed but the real improvement is undocumented.

The fifth mistake is missing training records. ISO 13485 requires that training on new procedures (resulting from CAPA) is documented. The CAPA workflow must integrate with training records – otherwise an audit gap opens. We design these elements with clients as part of implementation and growth with Quality team involvement.

Is Power Platform validated for GxP? Microsoft provides GxP attestation for Microsoft 365 and Power Platform as vendor qualification (Microsoft Trust Center document). Application validation (URS/FS/DS/IQ/OQ/PQ) is still required – platform validation does not replace application validation.

Can I use Power Platform without a dedicated QMS? Yes, for small and mid-size organisations this is often sufficient. Larger organisations (more than a few dozen CAPAs per month) typically use a hybrid: dedicated QMS for the regulatory backbone + Power Platform for UX modernisation and integrations.

How long does a compliant CAPA workflow rollout take? Full cycle: process design (4–8 weeks) + workflow build (6–10 weeks) + CSV (12–20 weeks) + training + go-live = 9–15 months in total. Scale depends on product portfolio, regulations and existing QMS.

Does FDA 21 CFR Part 11 apply to my company if we only sell in the EU? Not directly. But MDR has similar requirements for electronic records, and most companies also sell to the US. In practice, designing to FDA Part 11 also delivers MDR compliance.

Is the CAPA workflow suitable for pharma and biotech? Yes, with an additional GxP layer – the same Power Platform + SharePoint stack is widely used in pharma and biotech, with dedicated adaptations for GMP, GLP, GCP. It requires deeper CSV.

How does Copilot help with CAPA? In areas like: drafting investigation reports with similar past CAPAs, quarterly root cause pattern analysis, drafting PSUR sections, summaries for management review. All under control – with AI governance tailored to the industry.

CAPA workflow in medtech combines the hardest elements of enterprise automation: rigorous regulation, CSV requirements, 10+ year audit trail, integrations with the rest of the QMS and (increasingly) an AI layer. It is not a quick project – it is a 9–15 month deployment with Quality, IT, Compliance and Operations.

Power Platform + SharePoint today offer the fastest path to a modern, compliant CAPA workflow for organisations already on Microsoft 365. It still requires a professional architecture design, computer system validation and ongoing governance discipline. Without these elements the investment becomes a regulatory risk.

The most sensible first step is an assessment of the current CAPA state in the organisation: where the records live, what the regulatory gaps are, how the integration with the rest of the QMS looks. From there the rest unfolds as a phased programme. At AlgorComp we support medtech clients across the full cycle – from assessment through validation to go-live.